Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson’s Disease with Motor Fluctuations

<div>Final daily LD dose ratios (black bars) and ER CD-LD daily dosing frequency (gray bars) based on daily LD dose ranges at study entry for the conversion from IR CD-LD (a) or CLE (b).</div>

Parkinson’s Disease

fig1

Figure 1

Figure 1: Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson’s Disease with Motor Fluctuations 

Figure 1 | Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson’s Disease with Motor Fluctuations 